The UK charity for WM & LPL – a rare type of blood cancer

Support Line: 0300 373 8500

Factsheet: How to access zanubrutinib

March 15, 2024

We know patients are concerned about accessing zanubrutinib...

Following the decision from the National Institute for Clinical Excellence (NICE), we know patients are concerned about accessing zanubrutinib. We’ve put together this handy guide to help you access it (and what you need to ask your consultant).

Related Documents

non-IgM LPL Fact Sheet
Our guide for those diagnosed with LPL
WMUK Brochure
Find out all about WMUK
Related conditions and symptoms of WM
Understanding Related Conditions and Symptoms of Waldenström’s Macroglobulinaemia (WM)